EPIX Kapitalisasi Akuntansi ESSA Pharma

ESSA Pharma Inc. (EPIX) focuses on developing specific inhibitors to combat resistant prostate tumors. However, the lack of commercialized drugs and the failure of several tests have erased its pricing power, leaving indicators at 0.11. Meanwhile, the company maintains its status as a scientific leader due to innovative receptor blocking methods. This daily price chart below clearly demonstrates the market valuation of this biotechnological project.

EPIX Kapitalisasi Buku ESSA Pharma Inc. (04.07.2022 - 25.10.2025)

Rincian metrik keuangan lan pasar ESSA Pharma Inc (EPIX)

- rega lan prakiraan konsensus rega:

Bagan bursa ESSA Pharma Inc.|EPIX - Target konsensus

- data kapitalisasi pasar:

Kapitalisasi pasar ESSA Pharma, Inc.|EPIX - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham ESSA Pharma|EPIX - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku essapharma.com|EPIX - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Utang marang Ekuitas ESSA Pharma Inc.|EPIX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas ESSA Pharma Inc.|EPIX - Gunggung utang perusahaan|Utang-utang marang nilai buku ESSA Pharma, Inc.

Ringkesan analisis perusahaan:ESSA Pharma - EPIX

Balance capitalization measures the market value of net equity, combining financial reporting data with current quotes to assess the real value of assets minus liabilities. For ESSA Pharma Inc. (EPIX), which invests in bioethical targeted therapy and ESG standards, the current state of balance capitalization serves as an indicator of financial foundation stability during the implementation of costly clinical trials.

Pesaing ESSA Pharma Inc.